Global Substance Abuse Disorder Treatment Market
Global Substance Abuse Disorder Treatment Research Analysis Report 2024: Public and Private Entities Join Forces to Tackle Substance Abuse Epidemic - Forecasts to 2034
January 31, 2024 09:44 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Substance Abuse Disorder Treatment Market Analysis & Forecast 2024-2034: Market By Treatment; By End-user; and By Region" report has been...
2.png
Talkspace and Bicycle Health Partner to Expand Access to Virtual Care for Patients with Opioid Use Disorder
January 30, 2024 09:00 ET | Bicycle Health
Millions Struggle with Substance Use Disorder and Mental Health: 7.7 million adults have a co-occurring substance use disorder and mental health condition. More than half receive treatment for neither...
2.png
Bicycle Health Publishes First-Ever Peer-Reviewed Research of Telehealth Treatment for Poppy Seed Tea Misuse
January 09, 2024 09:00 ET | Bicycle Health
While poppy seeds are a legal substance, misuse of poppy seed tea can lead to opioid misuse, contribute to overdose and death Published in the Journal of Addictive Diseases, this first-of-its-kind...
FORE Awards $900,000
FORE Awards $900,000 in New Grants to Improve Access to Lifesaving Medications for Opioid Use Disorder in Pharmacies Nationwide
December 05, 2023 11:04 ET | Foundation for Opioid Response Efforts
New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Only about 18% of people with opioid use disorder report the use of lifesaving medications like buprenorphine in their recovery, despite efforts to...
BayMarkLogoWithTagvFinal.png
BayMark Releases Whitepaper: 2023 Nationwide Opioid Use Disorder Treatment Outcomes Report
November 29, 2023 08:30 ET | BayMark Health Services
Comprehensive report analyzes clinical outcomes from ~39k patients in BayMark's outpatient medication-assisted treatment programs.
Asset 3
Bicycle Health & Wellpath Collaborate to Reduce Recidivism and Overdose Deaths by Providing Injectable Buprenorphine in Federal Residential Reentry Centers for the Federal Bureau of Prisons (FBOP)
November 16, 2023 09:00 ET | Bicycle Health
Medication for opioid use disorder (MOUD) is considered the gold standard of care for individuals with opioid use disorder (OUD).The Consolidated Appropriations Act, 2023 (CAA), signed by President...
image003.png
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 14, 2023 07:30 ET | DMK Pharmaceuticals Corporation
Rebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid related deaths through enhanced sales of ZIMHI®...
image003.png
DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
November 13, 2023 10:52 ET | DMK Pharmaceuticals Corporation
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for...
2.png
Bicycle Health Commends U.S. Drug Enforcement Administration as It Extends Telemedicine Rule Through the End of 2024
October 06, 2023 18:00 ET | Bicycle Health
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s largest virtual provider of integrated medical and behavioral healthcare for opioid use disorder (OUD), is excited to see the...
22157.jpg
Opioid Use Disorder Market Insights, Epidemiology and Forecasts, 2032: Treatment, Drug Class, Therapies, Outlook, Pipeline Activities, Treatment Programs
September 29, 2023 10:13 ET | Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...